Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.

作者: Sandrine de Montgolfier , Gregoire Moutel , Nathalie Duchange , Ioannis Theodorou , Christian Herve

DOI: 10.1097/00008571-200212000-00001

关键词:

摘要: The aim of this study was to analyse ethical issues concerning the storage human biological samples be used in genetic analyses and pharmacogenetic research based on a French experience DNA banking cohort immunodeficiency virus (HIV)-infected patients started protease inhibitor-containing treatment. We describe raised during establishment bank, including questions dealing with autonomy, benefit patient, information sharing confidentiality as well guarantees use DNA. practical applications themes illustrated theoretically literature are discussed. Most points not specific HIV, but some them may more accurate due characteristics HIV population, which is involved social debate through community life increased risk stigmatization. Our results summarized memorandum consent form presented Appendices. One issue still open discussion way data will given patients. This work should allow other researchers members evaluation committees enrich their considerations stimulate topic.

参考文章(27)
Laurence Meyer, Magdalena Magierowska, Jean-Baptiste Hubert, Christine Rouzioux, Christiane Deveau, Françoise Sanson, Patrice Debre, Jean-François Delfraissy, Ioannis Theodorou, Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS. ,vol. 11, ,(1997) , 10.1097/00002030-199711000-00001
M Deschênes, G Cardinal, BM Knoppers, KC Glass, Human genetic research, DNA banking and consent: a question of 'form'? Clinical Genetics. ,vol. 59, pp. 221- 239 ,(2001) , 10.1034/J.1399-0004.2001.590403.X
John A. Robertson, Consent and privacy in pharmacogenetic testing Nature Genetics. ,vol. 28, pp. 207- 209 ,(2001) , 10.1038/90032
Ségolène Duran, Bruno Spire, François Raffi, Véronique Walter, Damien Bouhour, Valérie Journot, Valérie Cailleton, Catherine Leport, Jean-Paul Moatti, , Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART HIV Clinical Trials. ,vol. 2, pp. 38- 45 ,(2001) , 10.1310/R8M7-EQ0M-CNPW-39FC
Philip R. Reilly, RETHINKING RISKS TO HUMAN SUBJECTS IN GENETIC RESEARCH American Journal of Human Genetics. ,vol. 63, pp. 682- 685 ,(1998) , 10.1086/302028
M. Dean, M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, S. J. O'Brien, , Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene Science. ,vol. 273, pp. 1856- 1862 ,(1996) , 10.1126/SCIENCE.273.5283.1856
Vincent Le Moing, Geneviève Chêne, Bernard Masquelier, Didier Sicard, Françoise Brun-Vézinet, Jacques Reynes, François Raffi, APROCO Study Group, Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. ,vol. 24, pp. 82- 83 ,(2000) , 10.1097/00042560-200005010-00016
Jürgen Brockmöller, Julia Kirchheiner, Christian Meisel, Ivar Roots, Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment. Pharmacogenomics. ,vol. 1, pp. 125- 151 ,(2000) , 10.1517/14622416.1.2.125
Bartha Maria Knoppers, Genetic information and the family: are we our brother's keeper? Trends in Biotechnology. ,vol. 20, pp. 85- 86 ,(2002) , 10.1016/S0167-7799(01)01879-0